InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-01-07 00:00:00 ET · period of report 2021-12-01 · accession 0001209191-22-002457 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-01-07 2021-12-01+ CPIX KAZIMI A J COB, CEO, Dir, 10% P - Purchase $4.54 +394 5.77M +0.0% +$1,790

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-08 P A 18 $6.15 5,770,277 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
2 Common Common Stock 2021-12-13 P A 30 $4.36 5,770,343 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
3 Common Common Stock 2021-12-14 P A 30 $4.28 5,770,373 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
4 Common Common Stock 2021-12-15 P A 30 $4.29 5,770,403 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
5 Common Common Stock 2021-12-16 P A 50 $4.53 5,770,453 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
6 Common Common Stock 2021-12-17 P A 50 $4.17 5,770,503 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
7 Common Common Stock 2021-12-20 P A 60 $4.33 5,770,563 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
8 Common Common Stock 2021-12-01 P A 18 $4.14 5,770,187 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
9 Common Common Stock 2021-12-09 P A 18 $5.81 5,770,295 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
10 Common Common Stock 2021-12-10 P A 18 $4.82 5,770,313 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
11 Common Common Stock 2021-12-02 P A 18 $3.84 5,770,205 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
12 Common Common Stock 2021-12-03 P A 18 $4.47 5,770,223 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
13 Common Common Stock 2021-12-06 P A 18 $4.46 5,770,241 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
14 Common Common Stock 2021-12-07 P A 18 $5.61 5,770,259 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.